Global RNA Modifying Agents Market Growth 2026-2032
The global RNA Modifying Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
United States market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key RNA Modifying Agents players cover Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?RNA Modifying Agents Industry Forecast? looks at past sales and reviews total world RNA Modifying Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected RNA Modifying Agents sales for 2026 through 2032. With RNA Modifying Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Modifying Agents industry.
This Insight Report provides a comprehensive analysis of the global RNA Modifying Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Modifying Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global RNA Modifying Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Modifying Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Modifying Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Modifying Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global RNA Modifying Agents market?
What factors are driving RNA Modifying Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Modifying Agents market opportunities vary by end market size?
How does RNA Modifying Agents break out by Type, by Application?
RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
United States market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for RNA Modifying Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key RNA Modifying Agents players cover Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?RNA Modifying Agents Industry Forecast? looks at past sales and reviews total world RNA Modifying Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected RNA Modifying Agents sales for 2026 through 2032. With RNA Modifying Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Modifying Agents industry.
This Insight Report provides a comprehensive analysis of the global RNA Modifying Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Modifying Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global RNA Modifying Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Modifying Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Modifying Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Modifying Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- N6-Methyladenosine (m6A) Antibody
- 5-Methylcytosine (5-mC) Antibody
- Others
- Gene Therapy
- Cancer Research
- Drug Development
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Active Motif
- Epigentek
- Thermo Fisher Scientific
- Merck
- Gene Link
- abcam
- ABclonal
- MyBioSource
- Beyotime
- Hologic
- Synaptic Systems
- Novus Biologicals
What is the 10-year outlook for the global RNA Modifying Agents market?
What factors are driving RNA Modifying Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Modifying Agents market opportunities vary by end market size?
How does RNA Modifying Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Modifying Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for RNA Modifying Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for RNA Modifying Agents by Country/Region, 2021, 2025 & 2032
2.2 RNA Modifying Agents Segment by Type
2.2.1 N6-Methyladenosine (m6A) Antibody
2.2.2 5-Methylcytosine (5-mC) Antibody
2.2.3 Others
2.2.4 RNA Modifying Agents Sales by Type
2.2.4.1 Global RNA Modifying Agents Sales Market Share by Type (2021-2026)
2.2.4.2 Global RNA Modifying Agents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global RNA Modifying Agents Sale Price by Type (2021-2026)
2.3 RNA Modifying Agents Segment by Application
2.3.1 Gene Therapy
2.3.2 Cancer Research
2.3.3 Drug Development
2.3.4 Other
2.3.5 RNA Modifying Agents Sales by Application
2.3.5.1 Global RNA Modifying Agents Sale Market Share by Application (2021-2026)
2.3.5.2 Global RNA Modifying Agents Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global RNA Modifying Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global RNA Modifying Agents Breakdown Data by Company
3.1.1 Global RNA Modifying Agents Annual Sales by Company (2021-2026)
3.1.2 Global RNA Modifying Agents Sales Market Share by Company (2021-2026)
3.2 Global RNA Modifying Agents Annual Revenue by Company (2021-2026)
3.2.1 Global RNA Modifying Agents Revenue by Company (2021-2026)
3.2.2 Global RNA Modifying Agents Revenue Market Share by Company (2021-2026)
3.3 Global RNA Modifying Agents Sale Price by Company
3.4 Key Manufacturers RNA Modifying Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Modifying Agents Product Location Distribution
3.4.2 Players RNA Modifying Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RNA MODIFYING AGENTS BY GEOGRAPHIC REGION
4.1 World Historic RNA Modifying Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global RNA Modifying Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global RNA Modifying Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic RNA Modifying Agents Market Size by Country/Region (2021-2026)
4.2.1 Global RNA Modifying Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global RNA Modifying Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas RNA Modifying Agents Sales Growth
4.4 APAC RNA Modifying Agents Sales Growth
4.5 Europe RNA Modifying Agents Sales Growth
4.6 Middle East & Africa RNA Modifying Agents Sales Growth
5 AMERICAS
5.1 Americas RNA Modifying Agents Sales by Country
5.1.1 Americas RNA Modifying Agents Sales by Country (2021-2026)
5.1.2 Americas RNA Modifying Agents Revenue by Country (2021-2026)
5.2 Americas RNA Modifying Agents Sales by Type (2021-2026)
5.3 Americas RNA Modifying Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Modifying Agents Sales by Region
6.1.1 APAC RNA Modifying Agents Sales by Region (2021-2026)
6.1.2 APAC RNA Modifying Agents Revenue by Region (2021-2026)
6.2 APAC RNA Modifying Agents Sales by Type (2021-2026)
6.3 APAC RNA Modifying Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe RNA Modifying Agents by Country
7.1.1 Europe RNA Modifying Agents Sales by Country (2021-2026)
7.1.2 Europe RNA Modifying Agents Revenue by Country (2021-2026)
7.2 Europe RNA Modifying Agents Sales by Type (2021-2026)
7.3 Europe RNA Modifying Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Modifying Agents by Country
8.1.1 Middle East & Africa RNA Modifying Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa RNA Modifying Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa RNA Modifying Agents Sales by Type (2021-2026)
8.3 Middle East & Africa RNA Modifying Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Modifying Agents
10.3 Manufacturing Process Analysis of RNA Modifying Agents
10.4 Industry Chain Structure of RNA Modifying Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Modifying Agents Distributors
11.3 RNA Modifying Agents Customer
12 WORLD FORECAST REVIEW FOR RNA MODIFYING AGENTS BY GEOGRAPHIC REGION
12.1 Global RNA Modifying Agents Market Size Forecast by Region
12.1.1 Global RNA Modifying Agents Forecast by Region (2027-2032)
12.1.2 Global RNA Modifying Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global RNA Modifying Agents Forecast by Type (2027-2032)
12.7 Global RNA Modifying Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Active Motif
13.1.1 Active Motif Company Information
13.1.2 Active Motif RNA Modifying Agents Product Portfolios and Specifications
13.1.3 Active Motif RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Active Motif Main Business Overview
13.1.5 Active Motif Latest Developments
13.2 Epigentek
13.2.1 Epigentek Company Information
13.2.2 Epigentek RNA Modifying Agents Product Portfolios and Specifications
13.2.3 Epigentek RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Epigentek Main Business Overview
13.2.5 Epigentek Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific RNA Modifying Agents Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck RNA Modifying Agents Product Portfolios and Specifications
13.4.3 Merck RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Gene Link
13.5.1 Gene Link Company Information
13.5.2 Gene Link RNA Modifying Agents Product Portfolios and Specifications
13.5.3 Gene Link RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gene Link Main Business Overview
13.5.5 Gene Link Latest Developments
13.6 abcam
13.6.1 abcam Company Information
13.6.2 abcam RNA Modifying Agents Product Portfolios and Specifications
13.6.3 abcam RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 abcam Main Business Overview
13.6.5 abcam Latest Developments
13.7 ABclonal
13.7.1 ABclonal Company Information
13.7.2 ABclonal RNA Modifying Agents Product Portfolios and Specifications
13.7.3 ABclonal RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ABclonal Main Business Overview
13.7.5 ABclonal Latest Developments
13.8 MyBioSource
13.8.1 MyBioSource Company Information
13.8.2 MyBioSource RNA Modifying Agents Product Portfolios and Specifications
13.8.3 MyBioSource RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MyBioSource Main Business Overview
13.8.5 MyBioSource Latest Developments
13.9 Beyotime
13.9.1 Beyotime Company Information
13.9.2 Beyotime RNA Modifying Agents Product Portfolios and Specifications
13.9.3 Beyotime RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beyotime Main Business Overview
13.9.5 Beyotime Latest Developments
13.10 Hologic
13.10.1 Hologic Company Information
13.10.2 Hologic RNA Modifying Agents Product Portfolios and Specifications
13.10.3 Hologic RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hologic Main Business Overview
13.10.5 Hologic Latest Developments
13.11 Synaptic Systems
13.11.1 Synaptic Systems Company Information
13.11.2 Synaptic Systems RNA Modifying Agents Product Portfolios and Specifications
13.11.3 Synaptic Systems RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Synaptic Systems Main Business Overview
13.11.5 Synaptic Systems Latest Developments
13.12 Novus Biologicals
13.12.1 Novus Biologicals Company Information
13.12.2 Novus Biologicals RNA Modifying Agents Product Portfolios and Specifications
13.12.3 Novus Biologicals RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Novus Biologicals Main Business Overview
13.12.5 Novus Biologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Modifying Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for RNA Modifying Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for RNA Modifying Agents by Country/Region, 2021, 2025 & 2032
2.2 RNA Modifying Agents Segment by Type
2.2.1 N6-Methyladenosine (m6A) Antibody
2.2.2 5-Methylcytosine (5-mC) Antibody
2.2.3 Others
2.2.4 RNA Modifying Agents Sales by Type
2.2.4.1 Global RNA Modifying Agents Sales Market Share by Type (2021-2026)
2.2.4.2 Global RNA Modifying Agents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global RNA Modifying Agents Sale Price by Type (2021-2026)
2.3 RNA Modifying Agents Segment by Application
2.3.1 Gene Therapy
2.3.2 Cancer Research
2.3.3 Drug Development
2.3.4 Other
2.3.5 RNA Modifying Agents Sales by Application
2.3.5.1 Global RNA Modifying Agents Sale Market Share by Application (2021-2026)
2.3.5.2 Global RNA Modifying Agents Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global RNA Modifying Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global RNA Modifying Agents Breakdown Data by Company
3.1.1 Global RNA Modifying Agents Annual Sales by Company (2021-2026)
3.1.2 Global RNA Modifying Agents Sales Market Share by Company (2021-2026)
3.2 Global RNA Modifying Agents Annual Revenue by Company (2021-2026)
3.2.1 Global RNA Modifying Agents Revenue by Company (2021-2026)
3.2.2 Global RNA Modifying Agents Revenue Market Share by Company (2021-2026)
3.3 Global RNA Modifying Agents Sale Price by Company
3.4 Key Manufacturers RNA Modifying Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Modifying Agents Product Location Distribution
3.4.2 Players RNA Modifying Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RNA MODIFYING AGENTS BY GEOGRAPHIC REGION
4.1 World Historic RNA Modifying Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global RNA Modifying Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global RNA Modifying Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic RNA Modifying Agents Market Size by Country/Region (2021-2026)
4.2.1 Global RNA Modifying Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global RNA Modifying Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas RNA Modifying Agents Sales Growth
4.4 APAC RNA Modifying Agents Sales Growth
4.5 Europe RNA Modifying Agents Sales Growth
4.6 Middle East & Africa RNA Modifying Agents Sales Growth
5 AMERICAS
5.1 Americas RNA Modifying Agents Sales by Country
5.1.1 Americas RNA Modifying Agents Sales by Country (2021-2026)
5.1.2 Americas RNA Modifying Agents Revenue by Country (2021-2026)
5.2 Americas RNA Modifying Agents Sales by Type (2021-2026)
5.3 Americas RNA Modifying Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Modifying Agents Sales by Region
6.1.1 APAC RNA Modifying Agents Sales by Region (2021-2026)
6.1.2 APAC RNA Modifying Agents Revenue by Region (2021-2026)
6.2 APAC RNA Modifying Agents Sales by Type (2021-2026)
6.3 APAC RNA Modifying Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe RNA Modifying Agents by Country
7.1.1 Europe RNA Modifying Agents Sales by Country (2021-2026)
7.1.2 Europe RNA Modifying Agents Revenue by Country (2021-2026)
7.2 Europe RNA Modifying Agents Sales by Type (2021-2026)
7.3 Europe RNA Modifying Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Modifying Agents by Country
8.1.1 Middle East & Africa RNA Modifying Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa RNA Modifying Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa RNA Modifying Agents Sales by Type (2021-2026)
8.3 Middle East & Africa RNA Modifying Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Modifying Agents
10.3 Manufacturing Process Analysis of RNA Modifying Agents
10.4 Industry Chain Structure of RNA Modifying Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Modifying Agents Distributors
11.3 RNA Modifying Agents Customer
12 WORLD FORECAST REVIEW FOR RNA MODIFYING AGENTS BY GEOGRAPHIC REGION
12.1 Global RNA Modifying Agents Market Size Forecast by Region
12.1.1 Global RNA Modifying Agents Forecast by Region (2027-2032)
12.1.2 Global RNA Modifying Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global RNA Modifying Agents Forecast by Type (2027-2032)
12.7 Global RNA Modifying Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Active Motif
13.1.1 Active Motif Company Information
13.1.2 Active Motif RNA Modifying Agents Product Portfolios and Specifications
13.1.3 Active Motif RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Active Motif Main Business Overview
13.1.5 Active Motif Latest Developments
13.2 Epigentek
13.2.1 Epigentek Company Information
13.2.2 Epigentek RNA Modifying Agents Product Portfolios and Specifications
13.2.3 Epigentek RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Epigentek Main Business Overview
13.2.5 Epigentek Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific RNA Modifying Agents Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck RNA Modifying Agents Product Portfolios and Specifications
13.4.3 Merck RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Gene Link
13.5.1 Gene Link Company Information
13.5.2 Gene Link RNA Modifying Agents Product Portfolios and Specifications
13.5.3 Gene Link RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gene Link Main Business Overview
13.5.5 Gene Link Latest Developments
13.6 abcam
13.6.1 abcam Company Information
13.6.2 abcam RNA Modifying Agents Product Portfolios and Specifications
13.6.3 abcam RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 abcam Main Business Overview
13.6.5 abcam Latest Developments
13.7 ABclonal
13.7.1 ABclonal Company Information
13.7.2 ABclonal RNA Modifying Agents Product Portfolios and Specifications
13.7.3 ABclonal RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ABclonal Main Business Overview
13.7.5 ABclonal Latest Developments
13.8 MyBioSource
13.8.1 MyBioSource Company Information
13.8.2 MyBioSource RNA Modifying Agents Product Portfolios and Specifications
13.8.3 MyBioSource RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MyBioSource Main Business Overview
13.8.5 MyBioSource Latest Developments
13.9 Beyotime
13.9.1 Beyotime Company Information
13.9.2 Beyotime RNA Modifying Agents Product Portfolios and Specifications
13.9.3 Beyotime RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beyotime Main Business Overview
13.9.5 Beyotime Latest Developments
13.10 Hologic
13.10.1 Hologic Company Information
13.10.2 Hologic RNA Modifying Agents Product Portfolios and Specifications
13.10.3 Hologic RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hologic Main Business Overview
13.10.5 Hologic Latest Developments
13.11 Synaptic Systems
13.11.1 Synaptic Systems Company Information
13.11.2 Synaptic Systems RNA Modifying Agents Product Portfolios and Specifications
13.11.3 Synaptic Systems RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Synaptic Systems Main Business Overview
13.11.5 Synaptic Systems Latest Developments
13.12 Novus Biologicals
13.12.1 Novus Biologicals Company Information
13.12.2 Novus Biologicals RNA Modifying Agents Product Portfolios and Specifications
13.12.3 Novus Biologicals RNA Modifying Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Novus Biologicals Main Business Overview
13.12.5 Novus Biologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. RNA Modifying Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. RNA Modifying Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of N6-Methyladenosine (m6A) Antibody
Table 4. Major Players of 5-Methylcytosine (5-mC) Antibody
Table 5. Major Players of Others
Table 6. Global RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 7. Global RNA Modifying Agents Sales Market Share by Type (2021-2026)
Table 8. Global RNA Modifying Agents Revenue by Type (2021-2026) & ($ million)
Table 9. Global RNA Modifying Agents Revenue Market Share by Type (2021-2026)
Table 10. Global RNA Modifying Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global RNA Modifying Agents Sale by Application (2021-2026) & (K Units)
Table 12. Global RNA Modifying Agents Sale Market Share by Application (2021-2026)
Table 13. Global RNA Modifying Agents Revenue by Application (2021-2026) & ($ million)
Table 14. Global RNA Modifying Agents Revenue Market Share by Application (2021-2026)
Table 15. Global RNA Modifying Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global RNA Modifying Agents Sales by Company (2021-2026) & (K Units)
Table 17. Global RNA Modifying Agents Sales Market Share by Company (2021-2026)
Table 18. Global RNA Modifying Agents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global RNA Modifying Agents Revenue Market Share by Company (2021-2026)
Table 20. Global RNA Modifying Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers RNA Modifying Agents Producing Area Distribution and Sales Area
Table 22. Players RNA Modifying Agents Products Offered
Table 23. RNA Modifying Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global RNA Modifying Agents Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global RNA Modifying Agents Sales Market Share Geographic Region (2021-2026)
Table 28. Global RNA Modifying Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global RNA Modifying Agents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global RNA Modifying Agents Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global RNA Modifying Agents Sales Market Share by Country/Region (2021-2026)
Table 32. Global RNA Modifying Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global RNA Modifying Agents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 35. Americas RNA Modifying Agents Sales Market Share by Country (2021-2026)
Table 36. Americas RNA Modifying Agents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 38. Americas RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 39. APAC RNA Modifying Agents Sales by Region (2021-2026) & (K Units)
Table 40. APAC RNA Modifying Agents Sales Market Share by Region (2021-2026)
Table 41. APAC RNA Modifying Agents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 43. APAC RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 44. Europe RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 45. Europe RNA Modifying Agents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 47. Europe RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of RNA Modifying Agents
Table 53. Key Market Challenges & Risks of RNA Modifying Agents
Table 54. Key Industry Trends of RNA Modifying Agents
Table 55. RNA Modifying Agents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. RNA Modifying Agents Distributors List
Table 58. RNA Modifying Agents Customer List
Table 59. Global RNA Modifying Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global RNA Modifying Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas RNA Modifying Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC RNA Modifying Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC RNA Modifying Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe RNA Modifying Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa RNA Modifying Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global RNA Modifying Agents Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global RNA Modifying Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global RNA Modifying Agents Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global RNA Modifying Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Active Motif Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 74. Active Motif RNA Modifying Agents Product Portfolios and Specifications
Table 75. Active Motif RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Active Motif Main Business
Table 77. Active Motif Latest Developments
Table 78. Epigentek Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. Epigentek RNA Modifying Agents Product Portfolios and Specifications
Table 80. Epigentek RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Epigentek Main Business
Table 82. Epigentek Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific RNA Modifying Agents Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Merck Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck RNA Modifying Agents Product Portfolios and Specifications
Table 90. Merck RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Gene Link Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. Gene Link RNA Modifying Agents Product Portfolios and Specifications
Table 95. Gene Link RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Gene Link Main Business
Table 97. Gene Link Latest Developments
Table 98. abcam Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. abcam RNA Modifying Agents Product Portfolios and Specifications
Table 100. abcam RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. abcam Main Business
Table 102. abcam Latest Developments
Table 103. ABclonal Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 104. ABclonal RNA Modifying Agents Product Portfolios and Specifications
Table 105. ABclonal RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. ABclonal Main Business
Table 107. ABclonal Latest Developments
Table 108. MyBioSource Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 109. MyBioSource RNA Modifying Agents Product Portfolios and Specifications
Table 110. MyBioSource RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. MyBioSource Main Business
Table 112. MyBioSource Latest Developments
Table 113. Beyotime Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 114. Beyotime RNA Modifying Agents Product Portfolios and Specifications
Table 115. Beyotime RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beyotime Main Business
Table 117. Beyotime Latest Developments
Table 118. Hologic Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 119. Hologic RNA Modifying Agents Product Portfolios and Specifications
Table 120. Hologic RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Hologic Main Business
Table 122. Hologic Latest Developments
Table 123. Synaptic Systems Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 124. Synaptic Systems RNA Modifying Agents Product Portfolios and Specifications
Table 125. Synaptic Systems RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Synaptic Systems Main Business
Table 127. Synaptic Systems Latest Developments
Table 128. Novus Biologicals Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 129. Novus Biologicals RNA Modifying Agents Product Portfolios and Specifications
Table 130. Novus Biologicals RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Novus Biologicals Main Business
Table 132. Novus Biologicals Latest Developments
Table 1. RNA Modifying Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. RNA Modifying Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of N6-Methyladenosine (m6A) Antibody
Table 4. Major Players of 5-Methylcytosine (5-mC) Antibody
Table 5. Major Players of Others
Table 6. Global RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 7. Global RNA Modifying Agents Sales Market Share by Type (2021-2026)
Table 8. Global RNA Modifying Agents Revenue by Type (2021-2026) & ($ million)
Table 9. Global RNA Modifying Agents Revenue Market Share by Type (2021-2026)
Table 10. Global RNA Modifying Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global RNA Modifying Agents Sale by Application (2021-2026) & (K Units)
Table 12. Global RNA Modifying Agents Sale Market Share by Application (2021-2026)
Table 13. Global RNA Modifying Agents Revenue by Application (2021-2026) & ($ million)
Table 14. Global RNA Modifying Agents Revenue Market Share by Application (2021-2026)
Table 15. Global RNA Modifying Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global RNA Modifying Agents Sales by Company (2021-2026) & (K Units)
Table 17. Global RNA Modifying Agents Sales Market Share by Company (2021-2026)
Table 18. Global RNA Modifying Agents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global RNA Modifying Agents Revenue Market Share by Company (2021-2026)
Table 20. Global RNA Modifying Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers RNA Modifying Agents Producing Area Distribution and Sales Area
Table 22. Players RNA Modifying Agents Products Offered
Table 23. RNA Modifying Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global RNA Modifying Agents Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global RNA Modifying Agents Sales Market Share Geographic Region (2021-2026)
Table 28. Global RNA Modifying Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global RNA Modifying Agents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global RNA Modifying Agents Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global RNA Modifying Agents Sales Market Share by Country/Region (2021-2026)
Table 32. Global RNA Modifying Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global RNA Modifying Agents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 35. Americas RNA Modifying Agents Sales Market Share by Country (2021-2026)
Table 36. Americas RNA Modifying Agents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 38. Americas RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 39. APAC RNA Modifying Agents Sales by Region (2021-2026) & (K Units)
Table 40. APAC RNA Modifying Agents Sales Market Share by Region (2021-2026)
Table 41. APAC RNA Modifying Agents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 43. APAC RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 44. Europe RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 45. Europe RNA Modifying Agents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 47. Europe RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa RNA Modifying Agents Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa RNA Modifying Agents Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa RNA Modifying Agents Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of RNA Modifying Agents
Table 53. Key Market Challenges & Risks of RNA Modifying Agents
Table 54. Key Industry Trends of RNA Modifying Agents
Table 55. RNA Modifying Agents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. RNA Modifying Agents Distributors List
Table 58. RNA Modifying Agents Customer List
Table 59. Global RNA Modifying Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global RNA Modifying Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas RNA Modifying Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC RNA Modifying Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC RNA Modifying Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe RNA Modifying Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa RNA Modifying Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa RNA Modifying Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global RNA Modifying Agents Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global RNA Modifying Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global RNA Modifying Agents Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global RNA Modifying Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Active Motif Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 74. Active Motif RNA Modifying Agents Product Portfolios and Specifications
Table 75. Active Motif RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Active Motif Main Business
Table 77. Active Motif Latest Developments
Table 78. Epigentek Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. Epigentek RNA Modifying Agents Product Portfolios and Specifications
Table 80. Epigentek RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Epigentek Main Business
Table 82. Epigentek Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific RNA Modifying Agents Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Merck Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck RNA Modifying Agents Product Portfolios and Specifications
Table 90. Merck RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Gene Link Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. Gene Link RNA Modifying Agents Product Portfolios and Specifications
Table 95. Gene Link RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Gene Link Main Business
Table 97. Gene Link Latest Developments
Table 98. abcam Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. abcam RNA Modifying Agents Product Portfolios and Specifications
Table 100. abcam RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. abcam Main Business
Table 102. abcam Latest Developments
Table 103. ABclonal Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 104. ABclonal RNA Modifying Agents Product Portfolios and Specifications
Table 105. ABclonal RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. ABclonal Main Business
Table 107. ABclonal Latest Developments
Table 108. MyBioSource Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 109. MyBioSource RNA Modifying Agents Product Portfolios and Specifications
Table 110. MyBioSource RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. MyBioSource Main Business
Table 112. MyBioSource Latest Developments
Table 113. Beyotime Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 114. Beyotime RNA Modifying Agents Product Portfolios and Specifications
Table 115. Beyotime RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beyotime Main Business
Table 117. Beyotime Latest Developments
Table 118. Hologic Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 119. Hologic RNA Modifying Agents Product Portfolios and Specifications
Table 120. Hologic RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Hologic Main Business
Table 122. Hologic Latest Developments
Table 123. Synaptic Systems Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 124. Synaptic Systems RNA Modifying Agents Product Portfolios and Specifications
Table 125. Synaptic Systems RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Synaptic Systems Main Business
Table 127. Synaptic Systems Latest Developments
Table 128. Novus Biologicals Basic Information, RNA Modifying Agents Manufacturing Base, Sales Area and Its Competitors
Table 129. Novus Biologicals RNA Modifying Agents Product Portfolios and Specifications
Table 130. Novus Biologicals RNA Modifying Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Novus Biologicals Main Business
Table 132. Novus Biologicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of RNA Modifying Agents
Figure 2. RNA Modifying Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RNA Modifying Agents Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global RNA Modifying Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. RNA Modifying Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. RNA Modifying Agents Sales Market Share by Country/Region (2025)
Figure 10. RNA Modifying Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of N6-Methyladenosine (m6A) Antibody
Figure 12. Product Picture of 5-Methylcytosine (5-mC) Antibody
Figure 13. Product Picture of Others
Figure 14. Global RNA Modifying Agents Sales Market Share by Type in 2026
Figure 15. Global RNA Modifying Agents Revenue Market Share by Type (2021-2026)
Figure 16. RNA Modifying Agents Consumed in Gene Therapy
Figure 17. Global RNA Modifying Agents Market: Gene Therapy (2021-2026) & (K Units)
Figure 18. RNA Modifying Agents Consumed in Cancer Research
Figure 19. Global RNA Modifying Agents Market: Cancer Research (2021-2026) & (K Units)
Figure 20. RNA Modifying Agents Consumed in Drug Development
Figure 21. Global RNA Modifying Agents Market: Drug Development (2021-2026) & (K Units)
Figure 22. RNA Modifying Agents Consumed in Other
Figure 23. Global RNA Modifying Agents Market: Other (2021-2026) & (K Units)
Figure 24. Global RNA Modifying Agents Sale Market Share by Application (2025)
Figure 25. Global RNA Modifying Agents Revenue Market Share by Application in 2026
Figure 26. RNA Modifying Agents Sales by Company in 2026 (K Units)
Figure 27. Global RNA Modifying Agents Sales Market Share by Company in 2026
Figure 28. RNA Modifying Agents Revenue by Company in 2026 ($ millions)
Figure 29. Global RNA Modifying Agents Revenue Market Share by Company in 2026
Figure 30. Global RNA Modifying Agents Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global RNA Modifying Agents Revenue Market Share by Geographic Region in 2026
Figure 32. Americas RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 33. Americas RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 34. APAC RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 35. APAC RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 36. Europe RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 37. Europe RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 40. Americas RNA Modifying Agents Sales Market Share by Country in 2026
Figure 41. Americas RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Figure 42. Americas RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 43. Americas RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 44. United States RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC RNA Modifying Agents Sales Market Share by Region in 2026
Figure 49. APAC RNA Modifying Agents Revenue Market Share by Region (2021-2026)
Figure 50. APAC RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 51. APAC RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 52. China RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. India RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe RNA Modifying Agents Sales Market Share by Country in 2026
Figure 60. Europe RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Figure 61. Europe RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 62. Europe RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 63. Germany RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 64. France RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. UK RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa RNA Modifying Agents Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 71. Egypt RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of RNA Modifying Agents in 2026
Figure 77. Manufacturing Process Analysis of RNA Modifying Agents
Figure 78. Industry Chain Structure of RNA Modifying Agents
Figure 79. Channels of Distribution
Figure 80. Global RNA Modifying Agents Sales Market Forecast by Region (2027-2032)
Figure 81. Global RNA Modifying Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global RNA Modifying Agents Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global RNA Modifying Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global RNA Modifying Agents Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global RNA Modifying Agents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of RNA Modifying Agents
Figure 2. RNA Modifying Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RNA Modifying Agents Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global RNA Modifying Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. RNA Modifying Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. RNA Modifying Agents Sales Market Share by Country/Region (2025)
Figure 10. RNA Modifying Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of N6-Methyladenosine (m6A) Antibody
Figure 12. Product Picture of 5-Methylcytosine (5-mC) Antibody
Figure 13. Product Picture of Others
Figure 14. Global RNA Modifying Agents Sales Market Share by Type in 2026
Figure 15. Global RNA Modifying Agents Revenue Market Share by Type (2021-2026)
Figure 16. RNA Modifying Agents Consumed in Gene Therapy
Figure 17. Global RNA Modifying Agents Market: Gene Therapy (2021-2026) & (K Units)
Figure 18. RNA Modifying Agents Consumed in Cancer Research
Figure 19. Global RNA Modifying Agents Market: Cancer Research (2021-2026) & (K Units)
Figure 20. RNA Modifying Agents Consumed in Drug Development
Figure 21. Global RNA Modifying Agents Market: Drug Development (2021-2026) & (K Units)
Figure 22. RNA Modifying Agents Consumed in Other
Figure 23. Global RNA Modifying Agents Market: Other (2021-2026) & (K Units)
Figure 24. Global RNA Modifying Agents Sale Market Share by Application (2025)
Figure 25. Global RNA Modifying Agents Revenue Market Share by Application in 2026
Figure 26. RNA Modifying Agents Sales by Company in 2026 (K Units)
Figure 27. Global RNA Modifying Agents Sales Market Share by Company in 2026
Figure 28. RNA Modifying Agents Revenue by Company in 2026 ($ millions)
Figure 29. Global RNA Modifying Agents Revenue Market Share by Company in 2026
Figure 30. Global RNA Modifying Agents Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global RNA Modifying Agents Revenue Market Share by Geographic Region in 2026
Figure 32. Americas RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 33. Americas RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 34. APAC RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 35. APAC RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 36. Europe RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 37. Europe RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa RNA Modifying Agents Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa RNA Modifying Agents Revenue 2021-2026 ($ millions)
Figure 40. Americas RNA Modifying Agents Sales Market Share by Country in 2026
Figure 41. Americas RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Figure 42. Americas RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 43. Americas RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 44. United States RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC RNA Modifying Agents Sales Market Share by Region in 2026
Figure 49. APAC RNA Modifying Agents Revenue Market Share by Region (2021-2026)
Figure 50. APAC RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 51. APAC RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 52. China RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. India RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe RNA Modifying Agents Sales Market Share by Country in 2026
Figure 60. Europe RNA Modifying Agents Revenue Market Share by Country (2021-2026)
Figure 61. Europe RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 62. Europe RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 63. Germany RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 64. France RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. UK RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa RNA Modifying Agents Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa RNA Modifying Agents Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa RNA Modifying Agents Sales Market Share by Application (2021-2026)
Figure 71. Egypt RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries RNA Modifying Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of RNA Modifying Agents in 2026
Figure 77. Manufacturing Process Analysis of RNA Modifying Agents
Figure 78. Industry Chain Structure of RNA Modifying Agents
Figure 79. Channels of Distribution
Figure 80. Global RNA Modifying Agents Sales Market Forecast by Region (2027-2032)
Figure 81. Global RNA Modifying Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global RNA Modifying Agents Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global RNA Modifying Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global RNA Modifying Agents Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global RNA Modifying Agents Revenue Market Share Forecast by Application (2027-2032)
